Views | |
---|---|
Evaluation of drug-drug interactions of rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp substrates in patients with an advanced solid tumor | 65 |
listopada 2021 | grudnia 2021 | stycznia 2022 | lutego 2022 | marca 2022 | kwietnia 2022 | maja 2022 | |
---|---|---|---|---|---|---|---|
Evaluation of drug-drug interactions of rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp substrates in patients with an advanced solid tumor | 3 | 3 | 0 | 1 | 1 | 2 | 0 |
Views | |
---|---|
wysocki_et-al_evaluation_of_drug-drug_interactions_2019.pdf | 65 |
wysocki_et-al_evaluation_of_drug-drug_interactions_2019.odt | 6 |
Views | |
---|---|
United States | 44 |
Germany | 3 |
Vietnam | 3 |
Japan | 1 |
Poland | 1 |
Views | |
---|---|
Ashburn | 27 |
Woodbridge | 4 |
Hanoi | 3 |
Ann Arbor | 2 |
Fairfield | 2 |
Wilmington | 2 |
Chicago | 1 |
Des Moines | 1 |
Kraków | 1 |
Los Angeles | 1 |